VentriLabs is pleased to announce that Annica Grimberg Lignell joins VentriLabs as new member of the Board of Directors. Annica brings a broad industrial background with extensive experience in marketing, strategy, and business development. She will provide strategic insights to support VentriLabs’ continued growth and international expansion.

With a strong track record in market entry and commercialization strategies, Annica will play a key role in helping VentriLabs penetrate new markets, both through direct commercial initiatives and by identifying and creating soft-landing bridges across Europe and the United States.

Annica Grimberg Lignell says:

“I have been following VentriLabs closely for quite some time and have seen how the management and board have built a strong foundation for a successful business with significant global potential. I am truly impressed by the early customer traction VentriLabs has achieved and look forward to contributing more deeply with strategic input as the company prepares for upcoming market launches and establishment in Europe and the U.S.”

Einar Pontén, Chairman of the Board, expresses his enthusiasm about the appointment:

“We are delighted that Annica has chosen to join VentriLabs’ Board. Her valuable experience and strategic perspective in marketing, commercialization, and international growth will be instrumental as we continue to build VentriLabs’ business and prepare for the next phase of expansion”.

With the addition of Annica, VentriLabs further strengthens its strategic and commercial capabilities as it moves towards broader international market presence.

About VentriLabs
VentriLabs is a pioneering Biotech and MedTech company based in Gothenburg, Sweden, focused on developing innovative solutions for flow control and fluid transfer. The company’s proprietary technology enables gentle handling of delicate fluids with exceptional precision, sensitivity, and versatility. VentriLabs’ pump systems are designed for a wide range of applications—from general laboratory and bioprocessing use to advanced clinical systems involving extracorporeal blood circulation.

For more information, visit www.ventrilabs.com.